| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner
1 company
Bios Equity Cof, LP last filed a Form 4 in June 2025, as Director, 10% Owner at ACTU.
At the last filing, the largest reported position was 196,428 shares of ACTU. Net of sales, the ACTU filings show accumulation of 546,429 shares.
Bios Equity Cof, LP has 2 Form 4 filings on record from August 2024 to June 2025, all as Director, 10% Owner at Actuate Therapeutics (ACTU), 2024–2025.
The 33 reported transactions were 22 conversions, 4 open-market purchases, 3 option exercises and 3 open-market sales, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 2 purchases worth about $4.5M and 1 sale worth about $225K.
The largest open-market purchase was 500,000 shares of ACTU at an average $8.00 on August 14, 2024, about $4.0M. Twelve months later ACTU was down 10%.
The only open-market sale was 24,999 shares of ACTU at an average $9.00 on August 14, 2024, about $225K. Twelve months later ACTU was down 10%.
Shares as reported in the last Form 4 for each company; the most recent is from June 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 27, 2025 | ACTU Actuate Therapeutics, Inc. | Director, 10% Owner | Buy | 71,428 | $7.00 | $499,996.00 | +57.1% | +11.6% | -71.8% | |
| Aug 14, 2024 | ACTU Actuate Therapeutics, Inc. | Director, 10% Owner | Buy | 500,000 | $8.00 | $4,000,000.00 | -133.3% | -1.4% | -10.2% | |
| Aug 14, 2024 | ACTU Actuate Therapeutics, Inc. | Director, 10% Owner | Sell | 24,999 | $9.00 | $224,991.00 | -16.0% | -1.4% | -10.2% |